NCOA4 and neoplasm: This integrative approach, combining single-cell trajectory data, bulk-RNA-seq profiles, and clinical outcomes, therefore established three key differentiation states (PTC1-PTC3), a prognostic 34-gene signature (MCD&PRGs, Figure S3), and three molecularly distinct bulk tumor subtypes (Cluster 1–3).